Key facts
- This page summarizes Ruth Alon's Form 3 filing for Alpha Tau Medical Ltd. (DRTS).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 19:00.
Ruth Alon - 18 Mar 2026 Form 3 Insider Report for Alpha Tau Medical Ltd. (DRTS)
- Reporting relationship
- Director
- Issuer ticker
- DRTS
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 18 Mar 2026, 19:00:23 UTC
- Prior SEC filing
- 23 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ruth Alon
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ruth Alon filed Form 3 for Alpha Tau Medical Ltd. (DRTS) on 18 Mar 2026.
Change
- Previous filing in this sequence was filed on 23 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001796386
Primary reporting owner
Alon Ruth
- Relationship
- Director
- Address
- C/O ALPHA TAU MEDICAL, PO BOX 45044, JERUSALEM, ISRAEL
- Signature
- /s/ Ruth Alon
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DRTS
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 29,367
- Date
- 18 Mar 2026
- Ownership
- Direct
DRTS
holding
Restricted Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,680
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DRTS
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 8,945
- Exercise price
- $10.92
- Footnotes
- F2
DRTS
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 10,178
- Exercise price
- $7.19
- Footnotes
- F2
DRTS
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 46,905
- Exercise price
- $3.28
- Footnotes
- F2
DRTS
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 43,257
- Exercise price
- $2.98
- Footnotes
- F2
DRTS
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 24,460
- Exercise price
- $4.05
- Footnotes
- F2
DRTS
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 15,527
- Exercise price
- $6.41
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
Footnote F2
These are options to acquire ordinary shares, which have fully vested as of the date hereof.
Footnote F3
These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.